Vuori Kristiina MD

Director · Inhibrx Biosciences, Inc.

Every open-market stock purchase Vuori Kristiina MD has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where how the prices paid compare to where the stock trades now.

Total bought
$100.0K
Open-market buys
1
Companies
1
Last buy
Oct 3, 2024

Where the buys stand today

All reported buys

DateTickerSharesPriceValueFiling
Oct 3, 20246,667$15.00$100.0KSEC ↗

Follow new qualifying clusters involving Vuori Kristiina MD or other insiders

Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.

About this data

Figures are parsed from Vuori Kristiina MD's Form 4 filings on SEC EDGAR (CIK 1612627) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.